A portable photon-counting CT scanner developed using CERN’s Medipix3 technology receives FDA clearance, paving the way for broader clinical adoption

The PRISMAP programme, coordinated by CERN, has supplied 159 radionuclide batches for cancer research over the past five years

From the first colour X-rays to detecting forgeries in the art world, semiconductor chips based on those originally designed for particle physics experiments continue to impact society in new and unexpected ways thanks to CERN’s Medipix collaborations

Five-year extensions to CERN’s CLEAR and MEDICIS platforms will boost the impact of cutting-edge accelerator technologies in areas ranging from advanced medical treatments to aerospace electronics

Rope winding and giant pasta shapes meet particle physics in Fusillo, a new magnet prototype with possible medical applications in hadron therapy

Could the technology you are working on have applications outside high-energy physics? Submit your application for funding from the KT Fund or the Medical Applications Budget by 31 March

CERN partners with public and private organisations to improve stroke prevention, diagnosis and treatment

CERN has been contributing to developing technologies to improve hadron therapy for the past 30 years. Now, a team at CERN is working on new design concepts that would make the machines delivering hadron therapy much more compact and economically viable

CERN’s Workshop on Global Health brought together professionals from diverse sectors to tackle pressing health challenges. Join the public webinar on 26 November to discover the outcomes of the workshop.

Ugo Amaldi helped create a European network of cancer therapy centres using beams of ions, in particular carbon ions

Global healthcare issues – from prosthesis pain to severe burns – were targeted by four student teams in the I.FAST project’s third challenge-based initiative

Scientists are testing a new device to help target cancer cells more accurately in ion radiotherapy of head and neck tumours, which could help limit the treatment’s side effects. It includes Timepix3, a small particle detector developed at CERN